Texas 2015 - 84th Regular

Texas Senate Bill SB66

Filed
11/10/14  
Out of Senate Committee
 
Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 

Caption

Relating to the use of epinephrine auto-injectors on public school and open-enrollment charter school campuses and at or in transit to or from off-campus school events.

Impact

The legislation mandates that each school district and open-enrollment charter school adopt policies related to the maintenance, administration, and proper disposal of epinephrine auto-injectors. This act will considerably impact school health policies, emphasizing the importance of having trained personnel on-site to manage potential instances of anaphylaxis. Furthermore, it outlines the establishment of an advisory committee that includes physicians and nursing professionals to oversee implementation and ensure compliance with training and administration protocols.

Summary

SB66, titled the Cameron Espinosa Act, focuses on the use and management of epinephrine auto-injectors in public and charter schools within Texas. It establishes protocols for training school personnel to administer these auto-injectors effectively, ensuring preparedness for cases of anaphylaxis — a severe allergic reaction. The bill aims to create a safe environment for students at school campuses and while involved in off-campus events by enabling immediate response to allergic emergencies through readily available epinephrine auto-injectors.

Sentiment

Overall, the sentiment surrounding SB66 appears positive, with support focusing on enhancing student safety and health responsiveness within educational settings. School districts and health officials generally advocate for the bill, perceiving it as a crucial step towards better health management in schools. However, concerns may arise around the logistics of training, resource allocation, and maintaining an adequate supply of epinephrine auto-injectors.

Contention

While the bill is largely supported, some opposition may concern the financial implications of stocking epinephrine auto-injectors and the requirement for training personnel, as it could impose additional responsibilities on schools already facing budget constraints. Critics may also argue regarding the adequacy of state-funding provisions and the training effectiveness. Nonetheless, the bill underscores the necessity for protective measures to address life-threatening allergic reactions among students.

Companion Bills

TX HB566

Identical Relating to the use of epinephrine auto-injectors on public and open-enrollment charter school campuses and at off-campus school-sanctioned events.

TX HB2847

Relating to policies and training regarding the use of epinephrine auto-injectors by school districts and open-enrollment charter schools; providing immunity.

Previously Filed As

TX HB566

Relating to the use of epinephrine auto-injectors on public and open-enrollment charter school campuses and at off-campus school-sanctioned events.

Similar Bills

TX HB2847

Relating to policies and training regarding the use of epinephrine auto-injectors by school districts and open-enrollment charter schools; providing immunity.

TX SB1367

Relating to policies and training regarding the use of epinephrine auto-injectors by public institutions of higher education; providing immunity.

TX HB3851

Relating to policies and training regarding the use of epinephrine auto-injectors by public institutions of higher education; providing immunity.

TX SB629

Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.

TX SB1374

Relating to the administration of epinephrine medication by public and private schools.

TX HB2801

Relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools.

TX SB1619

Relating to the use of an epinephrine delivery system by certain entities.